Stefan Lohmer
Vorstandsvorsitzender bei Axxam SpA
Aktive Positionen von Stefan Lohmer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Axxam SpA
Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | Vorstandsvorsitzender | 01.01.2001 | - |
Vorsitzender | 01.01.2001 | - | |
Gründer | 01.01.2001 | - | |
Präsident | 01.01.2001 | - |
Karriereverlauf von Stefan Lohmer
Ehemalige bekannte Positionen von Stefan Lohmer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Acousia Therapeutics GmbH
Acousia Therapeutics GmbH BiotechnologyHealth Technology Acousia Therapeutics GmbH identifies small molecules for treatment of hearing loss. The firm develops drugs for local application, which will protect hearing function or restore hearing in patients who have lost their hearing ability due to various reasons. It also develops small molecule compounds that trigger regeneration of sensory hair cells and therefore allow casual treatment of sensorineural hearing loss in patients who already lost their hair cells years ago. The company was founded by Hubert Löwenheim and Karl-Heinz Wiesmüller in 2012 and is headquartered in Tübingen, Germany. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
Italien | 2 |
Deutschland | 2 |
Operativ
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Axxam SpA
Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | Commercial Services |
Acousia Therapeutics GmbH
Acousia Therapeutics GmbH BiotechnologyHealth Technology Acousia Therapeutics GmbH identifies small molecules for treatment of hearing loss. The firm develops drugs for local application, which will protect hearing function or restore hearing in patients who have lost their hearing ability due to various reasons. It also develops small molecule compounds that trigger regeneration of sensory hair cells and therefore allow casual treatment of sensorineural hearing loss in patients who already lost their hair cells years ago. The company was founded by Hubert Löwenheim and Karl-Heinz Wiesmüller in 2012 and is headquartered in Tübingen, Germany. | Health Technology |
- Börse
- Insiders
- Stefan Lohmer
- Erfahrung